H1B Report
Side-by-side comparison

Guardian Drug Company, Inc. vs Microsoft Corporation

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Guardian Drug Company, Inc.
NJRank #FEIN 22-2573413
Entity B
Microsoft Corporation
WARank #5FEIN 91-1144442

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricGuardian Drug Company, Inc.Microsoft Corporation
Total filings14272,912
Certified %90.85%94.30%
Denied %1.41%0.15%
Withdrawn %5.63%0.69%
Cert-withdrawn %2.11%4.85%
Rank#5
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJWA

Outcomes — Guardian Drug Company, Inc.

DOL case-status mix.

Outcome breakdown: Certified 90.9%, Cert-withdrawn 2.1%, Withdrawn 5.6%, Denied 1.4%
Outcome breakdown
OutcomeShare
Certified90.9%
Cert-withdrawn2.1%
Withdrawn5.6%
Denied1.4%
Certified90.9%
Cert-withdrawn2.1%
Withdrawn5.6%
Denied1.4%

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.3%, Cert-withdrawn 4.9%, Withdrawn 0.7%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Guardian Drug Company, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201115
FY20127
FY20138
FY201411
FY20155
FY201611
FY201711
FY201814
FY201911
FY20200
FY20210
FY20222
FY20230
FY202412
FY202516
FY20269
Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,407
FY20114,184
FY20124,005
FY20133,832
FY20143,674
FY20154,476
FY20164,919
FY20174,884
FY20185,457
FY20196,000
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20265,118

Top 5 occupations — Guardian Drug Company, Inc.

Top 5 occupations — Microsoft Corporation

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.